China’s first self-developed mRNA vaccine to enter mass production in October with annual capacity of 200 million doses
COVID-19: Pfizer vaccine: undecided for sale in mainland China
COVID-19: Chinese vaccine: Exports surge in July
COVID-19: US / State Infection Disparity: Vaccine Proven
COVID-19: Vietnam avoids Chinese vaccines: Sinopharm